Z Kallay
Overview
Explore the profile of Z Kallay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wawruch M, Slezakova V, Murin J, Kuzelova M, Dukat A, Zabka M, et al.
Bratisl Lek Listy
. 2015 Oct;
116(9):533-8.
PMID: 26435017
Background: The use of antiplatelet agents is strongly recommended for the secondary prevention of ischemic events such as myocardial infarction, stroke/transient ischemic attack (TIA). Objectives: The aim of our study...
2.
Bezek S, Soltes L, Scasnar V, Bauerova K, Kallay Z, Durisova M, et al.
Life Sci
. 1999 Nov;
65(18-19):2003-5.
PMID: 10576455
The aim of this paper is to provide a brief overview of most important results of stobadine kinetic studies in rats, dogs, and human volunteers. In these studies, stobadine dihydrochloride...
3.
Kovarik J, Mueller E, Kallay Z, Smith H, Lison A, Arns W, et al.
J Clin Pharmacol
. 1995 Dec;
35(12):1136-43.
PMID: 8750363
A concentration-guided study was designed to maintain adequate immunosuppression and avoid excessive drug exposure while determining steady-state relative bioavailability of two cyclosporine G (CyG) oral formulations in stable renal transplant...
4.
Mueller E, Kallay Z, Kovarik J, Richard F, Wiesinger O, Schmidt K, et al.
Transplantation
. 1995 Sep;
60(5):515-7.
PMID: 7676504
A microemulsion formulation of CsA, which was anticipated to be independent of bile for oral absorption, was compared with the currently marketed formulation in liver transplant patients with external biliary...
5.
Appel S, Rufenacht T, Kalafsky G, Tetzloff W, Kallay Z, Hitzenberger G, et al.
Am J Cardiol
. 1995 Jul;
76(2):29A-32A.
PMID: 7604792
Human drug interaction studies in vivo are conducted when in vitro and/or animal interactions suggest clinical relevance. Studies in vitro have indicated that the new, entirely synthetic 3-hydroxy-3-methylglutaryl coenzyme A...
6.
Fluckiger S, Schmidt C, Meyer A, Kallay Z, Johnston A, Kutz K
J Clin Pharmacol
. 1995 Jul;
35(7):681-7.
PMID: 7560248
Cyclosporine pharmacokinetics were reported to be influenced in patients with Crohn's disease. To explore the relationship between Crohn's disease and cyclosporine pharmacokinetics, this investigation was performed in 20 patients with...
7.
Mueller E, Kallay Z, Kovarik J, Arns W, Renner E, Kutz K
Transplant Proc
. 1995 Feb;
27(1):834-6.
PMID: 7879198
No abstract available.
8.
Kovarik J, Kallay Z, Mueller E, van Bree J, Arns W, Renner E
Transpl Int
. 1995 Jan;
8(5):335-9.
PMID: 7576013
Potential differences in the acute effect of cyclosporin on renal function when dosed orally as the current market formulation or following a milligram-to-milligram conversion to a new microemulsion formulation were...
9.
Piotrovskij V, Kallay Z, Horecky J, Trnovec T, Krumpl G, Krejcy K
Xenobiotica
. 1994 Jul;
24(7):663-9.
PMID: 7975730
1. NG-nitro-L-arginine (10, 30 and 100 mg/kg) was administered intravenously to the male Wistar rat. Plasma was collected over 48, 72 and 120 h and was analysed for the drug...
10.
Piotrovskij V, Kallay Z, Horecky J, Trnovec T, Raberger G, Krejcy K
Drug Metab Dispos
. 1994 Mar;
22(2):338-9.
PMID: 8013291
No abstract available.